HomeAKBA • NASDAQ
add
Akebia Therapeutics Inc
Previous close
$2.54
Day range
$2.53 - $2.64
Year range
$0.80 - $2.90
Market cap
685.48M USD
Avg Volume
4.22M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 57.34M | 75.84% |
Operating expense | 35.50M | -19.66% |
Net income | 6.11M | 133.98% |
Net profit margin | 10.66 | 119.33% |
Earnings per share | 0.02 | 129.30% |
EBITDA | 13.99M | 384.78% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 113.37M | 170.19% |
Total assets | 310.18M | 37.57% |
Total liabilities | 285.60M | 13.01% |
Total equity | 24.58M | — |
Shares outstanding | 262.64M | — |
Price to book | 28.22 | — |
Return on assets | 12.88% | — |
Return on capital | 19.01% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 6.11M | 133.98% |
Cash from operations | -13.59M | 30.08% |
Cash from investing | 154.00K | — |
Cash from financing | 74.94M | 305.64% |
Net change in cash | 61.51M | 6,527.27% |
Free cash flow | -15.80M | -44.62% |
About
Founded
Jan 1, 2007
Headquarters
Website
Employees
181
